Cargando…

PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study

INTRODUCTION: Gastric carcinoma with lymphoid stroma is an unusual type of gastric tumor associated with a better prognosis than typical gastric carcinomas. The hallmark of this cancer is a prominent lymphoid infiltration of the stroma that represents an intense host lymphocytic response. The progra...

Descripción completa

Detalles Bibliográficos
Autores principales: Crescenzi, Anna, Taffon, Chiara, Donati, Michele, Guarino, Michele Pier Luca, Valeri, Sergio, Coppola, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319490/
https://www.ncbi.nlm.nih.gov/pubmed/28207501
http://dx.doi.org/10.1097/MD.0000000000005730
_version_ 1782509389360398336
author Crescenzi, Anna
Taffon, Chiara
Donati, Michele
Guarino, Michele Pier Luca
Valeri, Sergio
Coppola, Roberto
author_facet Crescenzi, Anna
Taffon, Chiara
Donati, Michele
Guarino, Michele Pier Luca
Valeri, Sergio
Coppola, Roberto
author_sort Crescenzi, Anna
collection PubMed
description INTRODUCTION: Gastric carcinoma with lymphoid stroma is an unusual type of gastric tumor associated with a better prognosis than typical gastric carcinomas. The hallmark of this cancer is a prominent lymphoid infiltration of the stroma that represents an intense host lymphocytic response. The programmed death 1–programmed death-ligand 1 (PD-1/PD-L1) axis has recently emerged as a master immune checkpoint that controls antitumor immune responses against many neoplasms. PATIENT'S CONCERNS CASE STUDY AND OUTCOME: We report the case of a male patient with gastric carcinoma with lymphoid stroma with a large mass infiltrating the gastric wall without nodal metastasis. He is alive without disease 10 months after surgery. We focused the study on factors that potentially modulate the prognosis. In this setting we demonstrate, for the first time in this type of tumor, by immunohistochemistry a strong PD-L1 expression in neoplastic cell and the presence of PD-1 positive infiltrating lymphocytes. CONCLUSION: The applied approach may contribute to the knowledge about host reaction in such tumor and it may also be used for tumor precise identification on the endoscopic biopsy time before excision surgery.
format Online
Article
Text
id pubmed-5319490
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-53194902017-03-02 PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study Crescenzi, Anna Taffon, Chiara Donati, Michele Guarino, Michele Pier Luca Valeri, Sergio Coppola, Roberto Medicine (Baltimore) 4500 INTRODUCTION: Gastric carcinoma with lymphoid stroma is an unusual type of gastric tumor associated with a better prognosis than typical gastric carcinomas. The hallmark of this cancer is a prominent lymphoid infiltration of the stroma that represents an intense host lymphocytic response. The programmed death 1–programmed death-ligand 1 (PD-1/PD-L1) axis has recently emerged as a master immune checkpoint that controls antitumor immune responses against many neoplasms. PATIENT'S CONCERNS CASE STUDY AND OUTCOME: We report the case of a male patient with gastric carcinoma with lymphoid stroma with a large mass infiltrating the gastric wall without nodal metastasis. He is alive without disease 10 months after surgery. We focused the study on factors that potentially modulate the prognosis. In this setting we demonstrate, for the first time in this type of tumor, by immunohistochemistry a strong PD-L1 expression in neoplastic cell and the presence of PD-1 positive infiltrating lymphocytes. CONCLUSION: The applied approach may contribute to the knowledge about host reaction in such tumor and it may also be used for tumor precise identification on the endoscopic biopsy time before excision surgery. Wolters Kluwer Health 2017-02-17 /pmc/articles/PMC5319490/ /pubmed/28207501 http://dx.doi.org/10.1097/MD.0000000000005730 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 4500
Crescenzi, Anna
Taffon, Chiara
Donati, Michele
Guarino, Michele Pier Luca
Valeri, Sergio
Coppola, Roberto
PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study
title PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study
title_full PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study
title_fullStr PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study
title_full_unstemmed PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study
title_short PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study
title_sort pd-l1/pd-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319490/
https://www.ncbi.nlm.nih.gov/pubmed/28207501
http://dx.doi.org/10.1097/MD.0000000000005730
work_keys_str_mv AT crescenzianna pdl1pd1checkpointingastriccarcinomawithlymphoidstromacasereportwithimmunochemicalstudy
AT taffonchiara pdl1pd1checkpointingastriccarcinomawithlymphoidstromacasereportwithimmunochemicalstudy
AT donatimichele pdl1pd1checkpointingastriccarcinomawithlymphoidstromacasereportwithimmunochemicalstudy
AT guarinomichelepierluca pdl1pd1checkpointingastriccarcinomawithlymphoidstromacasereportwithimmunochemicalstudy
AT valerisergio pdl1pd1checkpointingastriccarcinomawithlymphoidstromacasereportwithimmunochemicalstudy
AT coppolaroberto pdl1pd1checkpointingastriccarcinomawithlymphoidstromacasereportwithimmunochemicalstudy